20 Years of Being Your Internet HIV/AIDS
Oral Healthcare Resource
     
     
 
 
IAC 2018 News
Updates from Day 4 of AIDS 2018

Criminalising HIV transmission is counterproductive and should stop, experts say
jm | July 26, 2018

Expert consensus statement on the science of HIV in the context of criminal law
JIAS | July 2018

Research Highlights Wrap-up from AIDS 2018 with NIH’s Dr. Carl Dieffenbach
HIV.gov | July 27, 2018

New Kaposi disease in 21 people with 3 years of HIV control in France
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Civil society under threat: How can HIV advocates resist the impact?

aidsmap | July 26, 2018

Really Rapid Review — International AIDS Conference 2018, Amsterdam

NEJM Journal Watch | July 29, 2018

 
IAC 2018 Research News
‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people
Jon CohenJul. 25, 2018

First Long-term Immune Response Data for Investigational HIV-1 Preventive Vaccine Announced by Johnson & Johnson
Johnson and Johnson | July 24, 2018

Kick-and-kill with vaccines plus vorinostat has no impact on CD4 reservoir
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Durable control of HIV infection in the absence of antiretroviral therapy Opportunities and obstacles
Anthony Fauci, National Institutes of Health (NIH), United States

Universal test-and-treat improves population viral suppression in rural South Africa
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
     
IAC 2018 Medical News

Noncommunicable disease rates with HIV lower in England than in 4 other countries

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Is the risk of myocardial infarction in PLHIV associated with atazanavir or darunavir exposure?

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Severe menopausal symptoms double odds of poor ART adherence in UK women

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Does Stigma Really Impact Health and Well-being in Persons Living with HIV(PLHIV)?

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

HIV incidence drops in Melbourne MSM, reflecting changing HIV testing and control
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
CD4 count and viral load tied to atherogenic cholesterol in people with HIV
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Mortality 4.5 times higher in Canadian women with HIV than in general population
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Mortality after ART starts remains higher in women in Americas and Africa than in Europe
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Half of adults in HIV group have insomnia--fewer than half of them treated
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Higher depression and anxiety rates with HIV across ART and viral load categories
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
HIV linked to higher risk of heart failure in 425,000-person US comparison
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Two-fold higher chance of liver steatosis with HIV in big Brazilian study
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
PrEP use rising in US MSM, but rectal STI rate remains stable
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
 
IAC 2018 Prevention News

Increase in STIs in PrEP users is concentrated in a minority of men and is partly due to more STI screening

aidsmap | 01 August 2018

The Impact of Pre-exposure Prophylaxis With FTC/TDF on HIV Diagnoses, 2012-2016, United States

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

One third of black MSM in NYC group experience partner violence
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Eight recent HIV outbreaks in drug injectors point to prevention complacency
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
Q and A - the PARTNER Study: new results from PARTNER 2
Gilead Announces New Data on the Impact of Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Pre-Exposure Prophylaxis (PrEP) on the Number of HIV Diagnoses in the United States
Businesswire | July 24, 2018

Incidence of HIV-infection in the ANRS Prevenir Study in the Paris Region with Daily or On Demand PrEP with TDF/FTC
IAC 2018 | July 26, 2018

Among 2590 US adolescents using PrEP, 83.5% are girls, 59% on Medicaid
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
     
IAC Medication News

Doravirine maintains higher rate of virological suppression over darunavir/ritonavir though 96 ...

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Patient Satisfaction, Tolerability and Acceptability of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting Therapy in HIV-1-Infected Adults: LATTE-2 Week 96 Results

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Treatment failure in 20% on ART in Australian group: toxicity main culprit
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Non-Inferior Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) vs DTG Plus Tenofovir/Emtricitabine (TDF/FTC) Fixed-Dose Combination in Antiretroviral Treatment-Naive Adults With HIV-1 Infection-Week 48 Results From the GEMINI Studies

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
ViiV Healthcare announces SWORD 100-week data for Juluca (dolutegravir/rilpivirine) at AIDS 2018
ViiV Healthcare | July 24, 2018

Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Businesswire | July 24, 2018

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario
PR Newswire | July 24, 2018

Dolutegravir/3TC noninferior to DTG/TDF/FTC at 48 weeks in big ART-naive group
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
 
IAC 2018 Pediatrics

Young adults with life-long HIV have a higher risk of cancer

aidsmap | 01 August 2018

   
 
IAC 2018 Mental Health

HIV Is Independently Linked to Poorer Mental Health

POZ | August 2, 2018

   
 
IAC 2018 HIV & Aging News
Liver enzyme spikes--then normalizes--when elderly start dolutegravir
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Possible link between HIV and vestibular impairment in men and women

22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018

Rates of kidney and bone disease--and multiple comorbidities--rising in elderly HIV group
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018